Myriad Genetics' Sell Thesis Is 'Largely Played Out' By: Benzinga via Benzinga February 08, 2017 at 09:33 AM EST Ladenburg Thalmann upgraded shares of Myriad Genetics, Inc. (NASDAQ: MYGN), premised on valuation, as it views that the sell thesis ... Read More >> Related Stocks: Myriad Genetics Inc